Guanhao BiotechLtd Bilan de santé

Santé financière contrôle des critères 0/6

Informations clés

17.8%

Ratio d'endettement

CN¥84.08m

Dette

Ratio de couverture des intérêts	-12.1x
Argent liquide	CN¥106.65m
Fonds propres	CN¥471.07m
Total du passif	CN¥259.25m
Total des actifs	CN¥730.32m

Mises à jour récentes de la santé financière

Pas de mise à jour

Guanhao BiotechLtd Bilan de santé

Santé financière contrôle des critères 0/6

Informations clés

Mises à jour récentes de la santé financière

Recent updates

Beijing Century TianFu Venture Capital Centre (Limited Partnership) acquired 2.89% stake in Guanhao Biotech Co.,Ltd. (SZSE:300238) from Guangzhou Zhiguang Biotechnology Co., Ltd. for CNY 85.4 million.

Third quarter 2024 earnings released: EPS: CN¥0.023 (vs CN¥0.04 in 3Q 2023)

Guanhao Biotech Co.,Ltd. to Report Q3, 2024 Results on Oct 29, 2024

Second quarter 2024 earnings released: EPS: CN¥0.027 (vs CN¥0.037 in 2Q 2023)

Guanhao Biotech Co.,Ltd. to Report First Half, 2024 Results on Aug 28, 2024

New minor risk - Share price stability

First quarter 2024 earnings released: EPS: CN¥0.05 (vs CN¥0.08 in 1Q 2023)

Guanhao Biotech Co.,Ltd. to Report Q1, 2024 Results on Apr 26, 2024

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 26, 2024

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 26, 2024

Full year 2023 earnings released: EPS: CN¥0.12 (vs CN¥1.16 loss in FY 2022)

Guanhao Biotech Co.,Ltd. to Report Fiscal Year 2023 Results on Mar 06, 2024

New minor risk - Share price stability

Third quarter 2023 earnings released: EPS: CN¥0.04 (vs CN¥0.046 in 3Q 2022)

Second quarter 2023 earnings released: EPS: CN¥0.037 (vs CN¥1.03 loss in 2Q 2022)

Guanhao Biotech Co.,Ltd. to Report First Half, 2023 Results on Aug 23, 2023

Guanhao Biotech Co.,Ltd. Announces Management Appointments

Full year 2022 earnings released: CN¥1.16 loss per share (vs CN¥0.28 profit in FY 2021)

High number of new and inexperienced directors

Third quarter 2022 earnings released: EPS: CN¥0.046 (vs CN¥0.08 in 3Q 2021)

Investor sentiment improved over the past week

Second quarter 2022 earnings released: CN¥1.03 loss per share (vs CN¥0.08 profit in 2Q 2021)

High number of new and inexperienced directors

Guanhao Biotech Co.,Ltd., Annual General Meeting, May 18, 2022

First quarter 2022 earnings released: EPS: CN¥0.08 (vs CN¥0.07 in 1Q 2021)

Third quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.04 in 3Q 2020)

Second quarter 2021 earnings released: EPS CN¥0.08 (vs CN¥0.062 in 2Q 2020)

First quarter 2021 earnings released: EPS CN¥0.07 (vs CN¥0.04 in 1Q 2020)

New 90-day low: CN¥18.95

Guanhao Biotech Co.,Ltd., Annual General Meeting, Mar 30, 2021

Full year 2020 earnings released: EPS CN¥0.18 (vs CN¥1.75 loss in FY 2019)

Guanhao Biotech Co.,Ltd. to Report Fiscal Year 2020 Results on Mar 09, 2021

New 90-day low: CN¥22.15

New 90-day high: CN¥29.88

New 90-day high: CN¥29.30

New 90-day low: CN¥23.15

Third quarter earnings released

Guanhao Biotech Co.,Ltd. to Report Q3, 2020 Results on Oct 27, 2020

Guanhao Biotech Co.,Ltd. (SZSE:300238) intends to acquire 31% stake in ZY Therapeutics Inc. from U.S.TIANYOU CAPITAL CORP for $3.1 million.

New 90-day high - CN¥38.39

Guanhao Biotech Co.,Ltd. to Report First Half, 2020 Results on Jul 21, 2020

Analyse de la situation financière

Historique et analyse du ratio d'endettement

Bilan

Découvrir des entreprises saines